US 12325750
Anti-Dectin-2 antibodies and methods of using
granted A61PA61P35/00
Quick answer
US patent 12325750 (Anti-Dectin-2 antibodies and methods of using) held by Bolt Biotherapeutics, Inc. expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bolt Biotherapeutics, Inc.
- Grant date
- Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P35/00